Spring Creek Capital’s Medpace MEDP Stock Holding History

Spring Creek Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,411	Closed	-$620K	–	416
2018 Q2	$620K	Buy	+14,411	New	+$582K	0.07%	301

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spring Creek Capital's MEDP Position: Q3 2018 in Review

Spring Creek Capital sold out of Medpace (MEDP) in Q3 2018, closing a stake of 14,411 shares — an estimated $620K sold.

Spring Creek Capital first reported a position in MEDP in Q2 2018 and held it in 1 quarter. The position peaked at $620K in Q2 2018. 207 funds tracked by Wall St. Rank hold MEDP as of Q3 2018.

Spring Creek Capital reported no remaining Medpace position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 14,411 Medpace shares in Q3 2018, an estimated $620K.
Spring Creek Capital first reported a position in Medpace in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Medpace position peaked at $620K in Q2 2018.
207 funds tracked by Wall St. Rank held Medpace as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.